Skip to content

To examine the saliva and blood for indicators of cell destruction patients with gum disease and type 2 diabetes mellitus.

Role of hepcidin-ferroportin axis in regulating iron homeostasis in generalised stage III/IV periodontitis with and without type 2 diabetes mellitus:A case-control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069584
Enrollment
84
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Sponsors

DrJanani M G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult males or females with healthy periodontium and with no systemic conditions Adult males or females with a diagnosis of type 2 diabetes mellitus and periodontitis Diabetes defined as those patients diagnosed with type 2 diabetes mellitus and are on oral hypoglycemic drugs for past one year with HbA1c lesser than equal to 10% Periodontitis defined as those patients with periodontal probing pocket depth greater than or equal to 6mm,clinical attachment loss greater than or equal to 5mm,full mouth plaque score greater than 20%,full mouth bleeding score greater than 10% with radiographic evidence of bone loss extending to middle or apical third of the root with at least 20 natural teeth excluding third molars

Exclusion criteria

Exclusion criteria: Patients under immunosuppressants and or antibiotics and or anti inflammatory medications and or any drugs that could influence the periodontium for past 6 months Pregnant or lactating mothers History of current and past smokers Previous history of periodontal or orthodontic therapy Patients receiving iron replacement therapy for anemia Patients with uncontrolled diabetes mellitus with HbA1c greater than 10% Patients with a history of any other systemic disease other than type 2 diabetes mellitus and those patients under insulin therapy will be excluded Subjects not willing to participate and not willing to give consent

Design outcomes

Primary

MeasureTime frame
Evaluating the role of hepcidin-ferroportin axis in regulating iron homeostasis in generalised stage iii/iv periodontitis with and without type 2 diabetes mellitus will further enhance our knowledge on the underlying molecular mechanisms mediating inflammation in periodontitis and in type 2 diabetes associated periodontitis Timepoint: There is no different time points in this study

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Devapriya Appukuttan

SRM Dental College, Chennai

devapriyamds@gmail.com9840197121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026